EBIMEV

US serial number:87206238
Application filling date:Oct. 17, 2016
Register:Principal
Mark type:Trademark
Status:Application has been published for opposition. The opposition period begins on the date of publication.
Status date:Jan. 24, 2017
Publication date:Jan. 24, 2017
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutic
Current owner owner name:Atara Biotherapeutics, Inc.
Current owner owner address:611 Gateway Blvd., Suite 900 South San Francisco, CALIFORNIA UNITED STATES 94080
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:David E. Heisey
Attorney email:JSalen@SheppardMullin.com
Attorney docket number:33PB-248498
Attorney email authorized:Yes
Correspondent name address:DAVID E. HEISEY SHEPPARD MULLIN RICHTER & HAMPTON LLP 12275 EL CAMINO REAL, SUITE 200 SAN DIEGO, CALIFORNIA UNITED STATES 92130-2006
Correspondent phone:(858) 720-8900
Correspondent email:JSalen@SheppardMullin.com Docketing@SheppardMullin.com
Correspondent fax:(858) 509-3691
Correspondent email authorized:Yes
Trademark staff tm attorney:PRATER, JILL I
Trademark staff law office assigned EBIMEV:LAW OFFICE 119

Reviews

Required fields are marked *